Omega Ob-Gyn Associates of South Arlington
Omega Ob-Gyn Associates of South Arlington was paid $4.96M by Medicaid between Jan 2018 and Dec 2024, across 37 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 34% of everything it billed.
33Billing provider infoOMEGA OB-GYN ASSOCIATES OF SOUTH ARLINGTON
ARLINGTON, TX 76015
ARLINGTON, TX 76015
33aNPI1154325850assigned 06/09/2005
33bProvider typeSpecialist
28Total paid$4.96M
24GClaims132,653
24DCodes billed37
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Texas
Rank by total paid#5 of 382
Median peer was paid$29K
This provider vs. median171×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47 | $132.02 | |
| 2019 | 17 | $46.72 | |
| 2020 | 6,693 | $210K | |
| 2021 | 34,954 | $1.39M | |
| 2022 | 36,034 | $1.34M | |
| 2023 | 30,062 | $1.10M | |
| 2024incomplete | 24,846 | $916K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 37,533 | 26,490 | $1.70M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 15% | 9,033 | 8,445 | $740K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 20,049 | 15,950 | $637K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 13% | 1,183 | 1,167 | $628K |
| 59430 | 5.3% | 2,895 | 2,748 | $260K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 4.7% | 2,292 | 2,239 | $233K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.7% | 1,756 | 1,730 | $135K |
| 81002 | 2.4% | 44,411 | 29,328 | $121K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 2.4% | 1,974 | 906 | $118K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.1% | 1,696 | 1,658 | $104K |
| 76830 | Ultrasound, transvaginal | 1.3% | 734 | 706 | $66K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 544 | 532 | $43K |
25 more codes
| 81025 | <1% | 4,792 | $31K | |
| 76813 | <1% | 223 | $20K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 299 | $19K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 263 | $18K |
| 99235 | <1% | 89 | $12K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 766 | $10K |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | <1% | 13 | $10K |
| 59514 | <1% | 13 | $8K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 161 | $7K |
| 87481 | <1% | 219 | $6K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 75 | $4K |
| 87529 | <1% | 177 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 157 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 157 | $2K |
| 87500 | <1% | 130 | $2K | |
| 87653 | <1% | 160 | $2K | |
| 87640 | <1% | 161 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 144 | $2K |
| 87511 | <1% | 157 | $2K | |
| 87641 | <1% | 130 | $1K | |
| 76801 | <1% | 14 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 45 | $970.03 |
| 58300 | <1% | 13 | $906.97 | |
| 87210 | <1% | 183 | $743.80 | |
| 99459 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGORDON, KEVIN (PARTNER)